Pharma news

A nationwide survey conducted in 2014-16 showed that around 3% medicines marketed in India were substandard, while around 0.023% were either spurious or counterfeit. Patients will soon be able to check whether the pill or syrup they’ve bought is genuine with just an SMS or a WhatsApp message, as pharmaceutical ...

Bipolar conference 2018 is the leading conference dedicated to Psychiatrists and Psychological researchers with the theme “Innovating combats towards Psychiatry & Mental Health”. The goal of Bipolar 2018 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of ...

Data science is the next wave of innovation with the potential to transform every stage of new drug discovery and development process. Leveraging advanced data analytics represents a significant opportunity for the pharma industry. In this bio-economy, data science is rapidly expanding as the raw material of business and economic ...

The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion in direct medical costs, according to a study published online March 22 in Diabetes Care. Under the direction of the American Diabetes Association, Wenya Yang, from The Lewin Group Inc. in Falls Church, Va., and colleagues ...

To promote research and intensify activities in infectious disease biology, the Department of Biotechnology (DBT) will soon begin research in the area of infectious disease biology for their evaluation and converting them into potential research programs to address issues in the area of ‘Repurposing of Drugs’. Read more @http://www.pharmabiz.com/NewsDetails.aspx?aid=103069&sid=1